Study finds that most still recommend the breast cancer screen for women in their early 40s
by PhilipJax on Thu Apr 20, 2017 02:47 AM
Preventing Death Due To Cachexia-Anorexia
Everyone, The National Cancer Institute estimates that 20% to 40% of cancer deaths are attributable to the wasting syndrome known as cachexia, which causes loss of appetite, lean body mass, body wasting, and which can lead to multiple organ failure. Identifying pre-cachexia is of crucial importance for effective intervention. Please study the following journal articles to learn how to treat this deadly condition. Then, check the medical records to learn whether these measures are being used. (The good care manager always gathers the latest records and keeps them on hand.). If the oncologist is not utilizing the anti-cachexia therapies, get one who will, and very quickly. Dithering also kills; this is a battle against time. PhilipJax >> http://jaxelection.altervista.org/pancreatic/CachexiaTreatme >> http://jaxelection.altervista.org/pancreatic/Cachexia2014The >> http://jaxelection.altervista.org/pancreatic/Nutrition2015Ge >> http://jaxelection.altervista.org/pancreatic/Supplements2016 >> http://jaxelection.altervista.org/pancreatic/Cachexia2015Mec >> http://www.cancernetwork.com/oncology-journal/evolving-appro , Italy >> http://www.cancernetwork.com/oncology-journal/early-engageme
by PhilipJax on Fri Apr 21, 2017 11:11 AM
New 2017 NCCN Guidelines for Pancreatic Adenocarcinoma
Everyone, NCCN has released its 2017 pancreatic clinical practice guidelines. Every care manager should study the document carefully (and study the last two years of posts on this site). The link is here. http://jaxelection.altervista.org/pancreatic/NCCN1.2017Pancr The following is a list of NCCN features by page number: > Pg-4, the new Evidence Block system > Pg-42, The ranking of chemo regimens using Evidence Blocks. Focus on the far-left column: Efficacy. > Pg-46, Staging code. Your overall-condition and biopsy reports should use this coding. > Pg-47, Details of the disease and therapies. > Pg-98, Indications for specific therapies. > Pg-2, Oncology leaders who authored this guideline. > Pg-6, Physician decision tree. With the exception of IRE, your physicians should be following this decision tool. Nearly half of treating physicians ignore these guidelines. See http://jaxelection.altervista.org/pancreatic/9_Pancreatic201 http://jaxelection.altervista.org/pancreatic/7_MDAnderson201 PhilipJax
by cdaley2 on Fri Apr 21, 2017 02:23 PM
Philip - this a an extremely important document, thank you so much for sending it along. It is shocking how much information some doctors hold back (or don't know). Chris
by tallysis on Sat Apr 22, 2017 04:11 AM
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
We care about your feedback. Let us know how we can improve your CancerCompass experience.